Conduit Pharmaceuticals Inc (CDT)

$1.74 +0.03 (1.75%)
Market Cap 5.41M
Revenue (ttm) 0.00
Net Income (ttm) -17.80M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 109,702
Avg Vol 422,744
Day's Range N/A - N/A
Shares Out 2.93M
Stochastic %K 5%
Beta 1.93
Analysts Strong Buy
Price Target N/A

Company Profile

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has stra...

Industry: Biotechnology
Sector: Healthcare
Phone: 646 491 9132
Address:
4581 Tamiami Trail North, Suite 200, Naples, United States
Pig2market
Pig2market Oct. 4 at 4:11 PM
$CDT stagnant all day everyday and no volume.
1 · Reply
Vikingsstrade
Vikingsstrade Oct. 3 at 7:39 PM
$CVM $CDT $CNEY $BON Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve!
0 · Reply
MrShubby
MrShubby Oct. 3 at 3:54 PM
$CDT might add more here
0 · Reply
Bears2354
Bears2354 Oct. 3 at 3:10 PM
$CDT
0 · Reply
Nevilhch
Nevilhch Oct. 3 at 12:04 PM
$CDT How's the sewer today? More Regan turds on top of us or what?
0 · Reply
HouseOfTheDragons
HouseOfTheDragons Oct. 3 at 2:58 AM
Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $RIME $NVFY $GSIW $CDT ,d
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 3 at 12:48 AM
$CDT $CNEY $BON $RNAZ |
0 · Reply
dantes13
dantes13 Oct. 2 at 9:42 PM
$CDT biggest garbage from them all and there are a lot of them but this one stand out,CEO know power of low float stock that is the fishhook he use every fucking time
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:42 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $AIFU $UOKA $CVM $CDT .
0 · Reply
DORO879
DORO879 Oct. 2 at 4:03 PM
$CDT i buy 550 shares today
0 · Reply
Latest News on CDT
CDT Executes Cryptocurrency Treasury Reserve Strategy

Sep 17, 2025, 8:30 AM EDT - 17 days ago

CDT Executes Cryptocurrency Treasury Reserve Strategy

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Aug 26, 2025, 8:30 AM EDT - 5 weeks ago

CDT Equity Identifies New Biological Target Validating AI-Driven Repurposing Strategy

Conduit to Change Name to CDT Equity Inc.

Aug 5, 2025, 8:30 AM EDT - 2 months ago

Conduit to Change Name to CDT Equity Inc.

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Jul 8, 2025, 8:30 AM EDT - 3 months ago

Conduit Engages Consultant to Explore Cryptocurrency Reserve Strategy

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Jul 7, 2025, 8:30 AM EDT - 3 months ago

Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Jun 4, 2025, 8:30 AM EDT - 4 months ago

Conduit Pharmaceuticals Enters Joint Development Agreement with Manoira to Advance AZD1656 and AZD5658 in Animal Health

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

May 22, 2025, 8:30 AM EDT - 4 months ago

Conduit Pharmaceuticals Inc. Listing on Nasdaq Capital Market

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

May 21, 2025, 8:30 AM EDT - 4 months ago

Conduit Pharmaceuticals Inc. Regains Nasdaq Compliance

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

May 16, 2025, 8:30 AM EDT - 5 months ago

Conduit Pharmaceuticals Inc. Announces Reverse Stock Split

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

May 9, 2025, 8:30 AM EDT - 5 months ago

Conduit Pharmaceuticals Receives Further Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

May 8, 2025, 8:30 AM EDT - 5 months ago

Conduit Pharmaceuticals Files Composition of Matter Patent for AZD5904 Creating Robust IP Foundation for Pipeline Asset

Conduit Pharmaceuticals Announces Leadership Changes

Apr 16, 2025, 8:30 AM EDT - 6 months ago

Conduit Pharmaceuticals Announces Leadership Changes

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Apr 11, 2025, 8:30 AM EDT - 6 months ago

Conduit Pharmaceuticals Announces Novel Cocrystal Patent Filing For VTAMA® (tapinarof) with Enhanced Therapeutic and Market Extension Prospects

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Mar 31, 2025, 8:30 AM EDT - 6 months ago

Conduit Pharmaceuticals Receives U.S. Patent Approval For Its Lead Asset Targeting Autoimmune Diseases

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Mar 19, 2025, 8:30 AM EDT - 7 months ago

Conduit Pharmaceuticals Provides Research and Development Update on Progress for Pipeline Assets AZD1656, AZD5658, and AZD5904

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Mar 6, 2025, 9:35 AM EST - 7 months ago

Conduit Pharmaceuticals Provides Update on Nasdaq Stock Market Hearing Panel

Conduit Progresses Phase II of its AI Initiative with Sarborg

Feb 20, 2025, 8:00 AM EST - 8 months ago

Conduit Progresses Phase II of its AI Initiative with Sarborg

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Feb 13, 2025, 8:00 AM EST - 8 months ago

Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Feb 11, 2025, 9:00 AM EST - 8 months ago

Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Feb 7, 2025, 8:00 AM EST - 8 months ago

Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Jan 28, 2025, 5:30 AM EST - 8 months ago

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Dec 12, 2024, 7:30 AM EST - 10 months ago

Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Nov 21, 2024, 7:30 AM EST - 11 months ago

Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Nov 19, 2024, 4:30 PM EST - 11 months ago

Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Nov 4, 2024, 7:30 AM EST - 11 months ago

Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Nov 1, 2024, 4:45 PM EDT - 1 year ago

Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Aug 12, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

Aug 8, 2024, 6:30 AM EDT - 1 year ago

Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments

AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​

May 22, 2024, 7:00 AM EDT - 1 year ago

AstraZeneca furthers ambition to transform outcomes in early lung cancer and ​redefine metastatic breast cancer treatment at ASCO 2024​

AZN

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

May 21, 2024, 8:00 AM EDT - 1 year ago

Daiichi Sankyo Highlights Progress in Creating New Standards of Care for Patients Across Multiple Cancers at ASCO

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Mar 19, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Mar 11, 2024, 7:00 AM EDT - 1 year ago

Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe's Leading Life Sciences Hub

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Jan 31, 2024, 8:30 AM EST - 1 year ago

Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 2 years ago

Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Oct 11, 2023, 8:30 AM EDT - 2 years ago

ClinConnect Partners with Conduit Pharmaceuticals on Cocrystal Development Program for AZD1656

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

Sep 22, 2023, 9:01 AM EDT - 2 years ago

Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination

Pig2market
Pig2market Oct. 4 at 4:11 PM
$CDT stagnant all day everyday and no volume.
1 · Reply
Vikingsstrade
Vikingsstrade Oct. 3 at 7:39 PM
$CVM $CDT $CNEY $BON Merger news on NITO and it barely has 3 million market cap. If people find this, short sellers could get hurt alot on NITO. Small caps have been dead for a while, but NITO gives me hope that short sellers finally get what they deserve!
0 · Reply
MrShubby
MrShubby Oct. 3 at 3:54 PM
$CDT might add more here
0 · Reply
Bears2354
Bears2354 Oct. 3 at 3:10 PM
$CDT
0 · Reply
Nevilhch
Nevilhch Oct. 3 at 12:04 PM
$CDT How's the sewer today? More Regan turds on top of us or what?
0 · Reply
HouseOfTheDragons
HouseOfTheDragons Oct. 3 at 2:58 AM
Looks like volume & momentum could be shifting in to ASTC! Tiny float getting a lot of attention and could explode upwards on volume. Watchers on ASTC are growing very fast and it could be the potential top runner for this week! Starting its 300% run - keep it on watch! Also watching for breakout: $RIME $NVFY $GSIW $CDT ,d
0 · Reply
MoonCowBoy
MoonCowBoy Oct. 3 at 12:48 AM
$CDT $CNEY $BON $RNAZ |
0 · Reply
dantes13
dantes13 Oct. 2 at 9:42 PM
$CDT biggest garbage from them all and there are a lot of them but this one stand out,CEO know power of low float stock that is the fishhook he use every fucking time
0 · Reply
1Spartantrade1
1Spartantrade1 Oct. 2 at 6:42 PM
Massive merger news 3 days ago on NITO! NITO has a low share count like TTNP (BTTC) does. TTNP ran 400% today. Can NITO also run 400%? Make sure to take profits. Lets see if NITO halts up today when people realize. $AIFU $UOKA $CVM $CDT .
0 · Reply
DORO879
DORO879 Oct. 2 at 4:03 PM
$CDT i buy 550 shares today
0 · Reply
Nevilhch
Nevilhch Oct. 1 at 5:44 PM
$CDT 18 days...
0 · Reply
East_Saxon_3
East_Saxon_3 Sep. 30 at 9:46 PM
$CDT LLOOLL read your own post. Transaction was the 19th. Old news. Someone shorting? 🔥😅
0 · Reply
Unalloyed
Unalloyed Sep. 30 at 6:13 PM
$CDT CEO just acquired 1.1 million shares as compensation
1 · Reply
Unalloyed
Unalloyed Sep. 30 at 6:11 PM
$CDT
0 · Reply
Unalloyed
Unalloyed Sep. 30 at 6:09 PM
$CDT
0 · Reply
MrShubby
MrShubby Sep. 30 at 5:04 PM
$CDT the dip before the rip?
3 · Reply
DipnRiptrader
DipnRiptrader Sep. 30 at 3:03 PM
$CDT Is this crap ever gonna move.
0 · Reply
Nevilhch
Nevilhch Sep. 30 at 1:37 PM
$CDT
0 · Reply
Nevilhch
Nevilhch Sep. 29 at 6:32 PM
$CDT do something
0 · Reply
SPYmyQQQ
SPYmyQQQ Sep. 26 at 10:03 PM
🚀 New Signal ✅ 💊 $CDT 🗓️ Sep 26, 2025 💵 Entry: $0.7200 🎯 Target (Opt.): $0.8422 (+16.97%) 👉 Check bio for full access
0 · Reply
Nevilhch
Nevilhch Sep. 26 at 5:17 PM
$CDT Well, let's average down a little bit more. 15 days already below 1 ... Tic - tac
1 · Reply
WIZARDTRADING
WIZARDTRADING Sep. 26 at 4:55 PM
$CDT good luck folks
0 · Reply